GlassScriptPhysician profile
A Narasimha Rao
NPI 1386890069
$1,789.55
in general payments reported to CMS, 2019-2025
24 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $161 · 2021: $251 · 2022: $370 · 2023: $434 · 2024: $200 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.27 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $178.39 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $161.23 | 2020-2021 | |
| Lilly USA, LLC | $147.88 | 2019-2025 | Zepbound, Kisunla, Amyvid |
| Argenx US, INC. | $109.42 | 2022-2025 | Vyvgart Hytrulo |
| Upsher-Smith Laboratories LLC | $108.47 | 2021-2023 | |
| Harmony Biosciences LLC | $101.05 | 2020-2023 | Wakix |
| Amgen INC. | $96.57 | 2022-2023 | Aimovig |
| Pfizer INC. | $78.13 | 2019-2024 | |
| Eisai INC. | $61.72 | 2023-2025 | |
| Lundbeck LLC | $60.47 | 2022-2023 | Vyepti |
| Genzyme Corporation | $54.82 | 2021-2022 | |
| Emd Serono, INC. | $49.68 | 2024-2025 | |
| Janssen Biotech, INC. | $43.38 | 2025 | |
| Novartis Pharmaceuticals Corporation | $41.42 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $27.17 | 2019 | |
| Ucb, INC. | $26.95 | 2022-2024 | Briviact |
| Itamar Medical INC | $26.00 | 2023 | Watchpatone |
| Axsome Therapeutics, INC. | $25.90 | 2024 | Sunosi |
| Impel Pharmaceuticals INC. | $18.91 | 2022 | |
| Sk Life Science, INC. | $14.62 | 2024 | |
| Genentech USA, INC. | $13.63 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.17 | 2022 | |
| Allergan, INC. | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw A Narasimha Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.